That is very important, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be reliable. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (white house). And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a breakthrough nearly no one observed. However it's going to have profound ramifications for curing disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be lots of financial investment opportunities in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (exponential tech investor). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it pulled back perhaps substantially before going higher - last week. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were primarily informing readers. However that's not the big concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. future report review. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are many excellent personal companies on the verge of striking the public markets And I've been working on a new method for you to invest even before these companies go public.
This opportunity has been building over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to schedule your spot totally free.
Emma Walsh here, managing editor of the Journal. Routine Diary readers know that tech isn't our usual beat (united states). And when it comes to tech investing, we leave it to the specialists. Fortunately, we have several such professionals in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing experts we understand (jeff brown 2021 stock predictions). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the big picture and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These patterns are experiencing rapid growth and producing incredible opportunities for investors. I desire to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. melania trump. However in spite of what numerous readers may think, this is a trend that's simply getting started. Although the COVID-19 pandemic interrupted supply chains last year, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (white house). Losing two months of manufacturing and sales really affects how many 5G gadgets are sold in the calendar year. When you think about all of that, selling 250 million systems is impressive. More significantly, the hold-ups triggered by the pandemic created a lots of pent-up need. Which need is now going to be pushed into 2021. In reality, I forecast that more than 500 million 5G devices will be shipped in 2021 - biotech stock. And that's not my only 5G forecast When I have actually discussed 5G in the past, I've explained its 3 various stages.
In Stage 2, 5G devices go on sale. 5G phones and other items start to reach customers. And in Stage 3, 5G services begin to be provided (tech predictions). That's when we begin to see applications running on 5G networks. Think about things like enormous multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Stage Three by this summer season. This starts something of a virtuous cycle: Many people don't really care about the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In fact, 5G is going to open up a suite of unbelievable applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment opportunities moving forward will be huge. Stepping away from 5G, the next important technology I visualize in 2021 is CRISPR hereditary modifying. CRISPR means "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not work properly. CRISPR uses a similar idea however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can correct these "typos." For years, CRISPR was mainly a niche technology that wasn't well comprehended. And during that time, there were really only 3 business operating in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating diseases and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering amazing returns. This whole industry is successfully a greenfield chance.
There's room for numerous business to exist in this area. jeff brown biotech stocks. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or 3 more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software can properly predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That is essential since the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has been an experimental process. And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to produce drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however a number of drug treatments produced using this innovation. This was one of those breakthroughs that almost no one saw. But it's going to have profound implications for curing illness. And, of course, there will be plenty of financial investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back maybe considerably before going greater. I've been covering bitcoin for a long time now. One of the very first research study reports I ever published was on bitcoin - jeff brown biotech stock pick for 2020. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my recommendation. However at the time of that preliminary suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. korean actress. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date as of February 2021, however we might not separately verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down an exact figure at this moment. Brown is best known for his sage-like capability to pick winning technology stocks. He invested more than 25 years looking into innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an excellent point of view on the market. He's always on the hunt for new chances, and he shares a number of his best choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully forecasted a few of the most significant financial occasions of the past twenty years. Although he doesn't appear to release his picks to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it right every time, but Jeff Brown's precise predictions have actually earned him legions of devoted followers. That states a lot about his capability. The Future Report is published by Brownstone Research study, a popular financial research publisher. Brownstone Research uses a number of research services with a variety of expertises - jeff brown tech stock 2021.
The business is likewise connected with Bonner & Partners, another well-respected research publisher - longtime readers. On its site, Brownstone says its objective is to supply retail investors with professional-grade research study: "For too long, the best investment research has not been readily available to private investors. It has actually been generally reserved for investment banks, hedge funds, personal equity, and high-net-worth customers. tech stock. The objective of Brownstone Research study is to make that type of proprietary research study readily available to any investors looking to get an edge in the markets. The goal is easy to deliver special and profitable financial investment research study found no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also serves as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After years of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you understand even a bit about the market, you know that he has a credibility as a King Midas of sorts. jeff bezos. Everything he touches turns to gold! Jeff is well conscious of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown thinks S.A.V. jeff brown 2021 stock picks. might be "the most significant trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding 2 innovative technologies: artificial intelligence and electrical cars and trucks. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing short of the vehicle market's Holy Grail. As you understand, electric vehicles and self-driving cars and truck stocks have been huge this year, however the Wall Street device has actually approved hype without much concrete outcome. Regardless of an extreme boost in competition over the past couple of years, Brown still thinks Musk has the best chance of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Vehicle, and it could be the future of transportation. Basically, this technology would enable you to lease out your vehicle as an autonomous, self-driving taxi when you're not using it. You just get out of the automobile and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you understand, you're unwinding on your couch while your car shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the revenues. It sounds ridiculous, but it could be closed than you think.